GW Pharmaceuticals (NASDAQ: GWPH) is a biopharmaceutical company which manufactures drugs derived from cannabis plant strains. The company’s shares have declined 30% in that many days despite its quarterly results beating analyst expectations on top line as well as bottom line...
